U.S. Markets close in 2 hrs 48 mins
  • S&P 500

    4,460.70
    -20.00 (-0.45%)
     
  • Dow 30

    34,657.78
    -156.61 (-0.45%)
     
  • Nasdaq

    15,109.67
    -51.86 (-0.34%)
     
  • Russell 2000

    2,249.73
    -25.88 (-1.14%)
     
  • Crude Oil

    69.39
    +1.04 (+1.52%)
     
  • Gold

    1,790.70
    -7.80 (-0.43%)
     
  • Silver

    23.95
    -0.38 (-1.58%)
     
  • EUR/USD

    1.1823
    -0.0025 (-0.2128%)
     
  • 10-Yr Bond

    1.3290
    +0.0250 (+1.92%)
     
  • Vix

    17.96
    -0.18 (-0.99%)
     
  • GBP/USD

    1.3773
    -0.0013 (-0.0909%)
     
  • USD/JPY

    110.2260
    -0.0330 (-0.0299%)
     
  • BTC-USD

    48,038.25
    -112.00 (-0.23%)
     
  • CMC Crypto 200

    1,234.41
    +1.12 (+0.09%)
     
  • FTSE 100

    7,095.53
    -53.84 (-0.75%)
     
  • Nikkei 225

    30,181.21
    +265.07 (+0.89%)
     

New Strong Sell Stocks for June 25th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

Calavo Growers, Inc. CVGW is a global avocado-industry leader and an expanding provider of value-added fresh food. The Zacks Consensus Estimate for its current year earnings has been revised nearly 16% downward over the last 30 days.

Chinook Therapeutics, Inc. KDNY is a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 1.9% downward over the last 30 days.

Comtech Telecommunications Corp. CMTL designs, develops, produces and markets innovative products, systems and services for advanced communications solutions. The Zacks Consensus Estimate for its current year earnings has been revised 3.4% downward over the last 30 days.

Great Panther Mining Limited GPL is engaged in the production of silver. The Zacks Consensus Estimate for its current year earnings has been revised 11.1% downward over the last 30 days.

Travere Therapeutics, Inc. TVTX is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 0.6% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Comtech Telecommunications Corp. (CMTL) : Free Stock Analysis Report
 
Great Panther Mining Limited (GPL) : Free Stock Analysis Report
 
Calavo Growers, Inc. (CVGW) : Free Stock Analysis Report
 
Chinook Therapeutics, Inc. (KDNY) : Free Stock Analysis Report
 
Travere Therapeutics, Inc. (TVTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research